Orthofix Medical Inc.

OFIX ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $545.6M
Cost of Revenue $138.5M
Gross Profit $407.2M
Gross Margin 74.6%
Operating Expenses
Research & Development $31.5M
SG&A Expense $88.9M
Operating Income $63.9M
Operating Margin 11.7%
Interest Expense $24.8M
Pretax Income $40.0M
Income Tax Expense $15.5M
Net Income $24.5M
Net Margin 4.5%
EPS (Basic) $1.43
EPS (Diluted) $1.42
Shares Outstanding (Basic) 17.1M
Shares Outstanding (Diluted) 17.2M
Dividends Per Share —
← Newer Page 3 of 3 Older →